VIIBRYD

Abbvie Corporation🇨🇦 Health Canada

Approval Id: b14eefa3917ccbdb
Drug Approval Canada Name: VIIBRYD
Product Name: VIIBRYD
Status: Cancelled Post Market
Status Date: 2023-07-20
Original Market Date: 2018-07-06
Din: 02443759
Drug Class: Human
Dosage Form: Tablet , Kit
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.24
Atc Original: N06AX24 VILAZODONE
Atc Name: n 06 ax 24
Aig Number: 0257130001
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

VILAZODONE HYDROCHLORIDE

10 MG

VILAZODONE HYDROCHLORIDE

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b14eefa3917ccbdb

Type

Standard